Nombre del producto:2-Cyclopropyl-7,7-dimethyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine

IUPAC Name:2-cyclopropyl-7,7-dimethyl-5H,6H,7H-pyrrolo[3,4-d]pyrimidine

CAS:947305-18-2
Fórmula molecular:C11H15N3
Pureza:95%+
Número de catálogo:CM270865
Peso molecular:189.26

Unidad de embalaje Stock disponible Precio($) Cantidad
CM270865-1g 1-2 Weeks Ɠůưǵ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :947305-18-2
Fórmula molecular:C11H15N3
Punto de fusión:-
Código de sonrisas:CC1(C)NCC2=CN=C(C3CC3)N=C21
Densidad:
Número de catálogo:CM270865
Peso molecular:189.26
Punto de ebullición:
Nº Mdl:MFCD16658060
Almacenamiento:

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.